LEP and amyotrophic lateral sclerosis: Additional adjustment for BMI for the association between leptin and ALS risk shifted the ORs over one, and test for trend was no longer statistically significant, indicating that leptin should be considered an intermediate factor on the causal pathway (and therefore BMI should not be included in the main model).